| Monitoring | Variables | Result | N | % | |
| 6 months | Cytopathology | Negative | 45 | 83.3 | |
| ASC-US | 8 | 14.8 | |||
| LSIL | 1 | 1.9 | |||
| Complications | Pain | 21 | 31.9 | ||
| Purulent flow | 5 | 9.3 | |||
| 12 Months | Cytopathology | Negative | 43 | 79.6 | |
|
| ASC-US | 9 | 16.6 | ||
|
| LSIL | 1 | 1.9 | ||
|
| HSIL | 1 | 1.9 | ||
| Colposcopy | Negative | 48 | 88.9 | ||
|
| Positive | 6 | 11.1 | ||
| Biopsy | Not performed | 45 | 83.3 | ||
| Negative | 4 | 7.4 | |||
| CIN 1 | 5 | 9.3 | |||
| General Status | No injury | 49 | 90.7 | ||
|
| Residual Injury | 5 | 9.3 | ||
| Long-term Complications | None | 51 | 94.4 | ||
|
| Pelvic Inflammatory Disease | 3 | 5.6 | ||
| 24 Months | Cytopathology | Negative | 46 | 85.1 | |
| ASC-US | 3 | 5.6 | |||
| LSIL | 3 | 5.6 | |||
| HSIL | 2 | 3.7 | |||
| Biopsy | Negative | 2 | 3.7 | ||
| CIN 1 | 3 | 5.5 | |||
| CIN 2/3 | 2 | 3.7 | |||
| Not Performed | 47 | 87.1 | |||